| NDC Code | 33332-219-20 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (33332-219-20) > .25 mL in 1 SYRINGE, GLASS (33332-219-21) |
|---|
| Product NDC | 33332-219 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Afluria Quadrivalent |
|---|
| Non-Proprietary Name | Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/maryland/15/2016 Antigen (propiolactone Inactivated), Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20190702 |
|---|
| End Marketing Date | 20200731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125254 |
|---|
| Manufacturer | Seqirus Pty Ltd. |
|---|
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 7.5; 7.5; 7.5; 7.5 |
|---|
| Strength Unit | ug/.25mL; ug/.25mL; ug/.25mL; ug/.25mL |
|---|